A new year often means higher prices for prescription medicines and 2020 is no exception.
As of Jan. 1, several drug makers raised list prices by approximately 5% or 6% for some of their best-selling medicines, according to analysts. So far, in fact, price hikes took effect on more than 300 medicines, according to 3 Axis Advisors, a data analytics and health care consulting firm. Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months! Log In | Learn More What is it? STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What's included? The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day Online intelligence briefings Frequent opportunities to engage with veteran beat reporters and industry experts Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more
Also in Industry News
1.5 Million Israelis Using Voluntary Coronavirus Monitoring App
ATS releases new guidance to help clinicians manage COVID-19 patients
Cancer patients face treatment delays and uncertainty as coronavirus cripples hospitals